Susan S. Jick, DSc

Director
Boston Collaborative Drug Surveillance Program, United States

Disclosure information not submitted.

Presentation(s):

• 2E-05 - Use of alternative study designs in evaluating comparative risks of infections among patients with moderate-to-severe psoriasis treated with newer vs. older immunomodulatory treatments

  Sunday, August 24, 2025
  4:30 PM - 4:45 PM ET

• 3B-02 - Risk of Incident Atrial Fibrillation among Female Users of Osteoporosis Treatments

  Monday, August 25, 2025
  8:30 AM - 8:45 AM ET